Getinge (OTCMKTS:GNGBY – Get Free Report) saw unusually-strong trading volume on Monday. Approximately 2,424 shares changed hands during trading, a decline of 20% from the previous session’s volume of 3,048 shares. The stock last traded at $25.1295 and had previously closed at $24.55.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the company. Nordea Equity Research downgraded Getinge from a “buy” rating to a “hold” rating in a report on Monday, August 31st. Zacks Research lowered shares of Getinge from a “strong-buy” rating to a “hold” rating in a research report on Thursday, September 17th. Pareto Securities lowered shares of Getinge from a “strong-buy” rating to a “hold” rating in a research report on Thursday. Finally, UBS Group assumed coverage on Getinge in a research report on Wednesday, September 2nd. They issued a “hold” rating on the stock. Four analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company currently has a consensus rating of “Hold”.
Read Our Latest Research Report on GNGBY
Getinge Trading Up 3.3%
Getinge (OTCMKTS:GNGBY – Get Free Report) last released its quarterly earnings results on Friday, July 17th. The company reported $0.38 earnings per share (EPS) for the quarter. Getinge had a return on equity of 11.12% and a net margin of 7.81%.The company had revenue of $894.87 million during the quarter. On average, sell-side analysts anticipate that Getinge will post 1.38 earnings per share for the current fiscal year.
About Getinge
Getinge AB is a Sweden-based medical technology company that develops products and solutions for hospitals, healthcare providers and life science organizations. Founded in 1904 in Getinge, Sweden, the company serves customers through operations and sales channels across Europe, North America, Asia-Pacific and other international markets.
Getinge organizes its business around Acute Care Therapies, Life Science and Surgical Workflows. Its offerings include ventilators, anesthesia systems, patient monitoring and cardiovascular support technologies, as well as equipment used in intensive care and other acute-care settings.
Featured Stories
- Five stocks we like better than Getinge
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
- Harley-Davidson Insiders Are Buying: Is HOG Finally Turning Around?
- 2 China-Focused ETFs For After the Trump-Xi Summit
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
